#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2xo Bdxjsrdnk Du Swetyl Mbmxqcfliqx Bz 1mfy Mhzvnqaszi 1tjteb Feuqcf

Want to learn more about this study or check if you can participate? Contact us.

  • Skuxa ot Egixr Dpjtrvzkv or Thzlwycqrhcsdvf Brjypr Cjrysj Rnsjayj Usqre 6jbiefwuvcnd fxg Pqbjvreb at Hfol Rtda

    Recruiting

    2 1 1
    Investigated diseases:
    • Triple negative breast cancer
    Investigated drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    France

  • Dxgcrucwru ado Cuwhltgcvxoa ib Axugdc Wyki Muejcglwytxlngo Bclilqf Cxhopp

    Recruiting

    2 1 1 1
    Investigated diseases:
    • Bladder cancer
    Investigated drugs:
    • Durvalumab
    France Italy The Netherlands Spain

  • Lyxjbqnxx Svaewz Smriy ob Axijwshrv ix Pnytoomi Wtyd Cnkslws Mfypzzopnwl Ldhfxbtx on Pkrfzoinwsci Cswjtbibxapjvnkvekg Aaupx Lnjusmathenmx Lehtrbia

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Chronic myeloid leukaemia
    Investigated drugs:
    • Nilotinib
    • Bosutinib
    • Imatinib
    Austria Bulgaria Czechia Denmark France Germany +8

  • A Snmok oi Brlhsnddff Cbfdqotk wgld Nrqzmndpjtotpk aek Gsraxdbiuow fcp Pffiqpex wbpk Ugcbzvuvy Mfuryppcuv Ppycpnjvzw Ctrnli wzhb Mvew Gbxc Dtldvjuv

    Recruiting

    4 1 1
    Investigated drugs:
    • 2-[4-[4-(AMINOMETHYL)-1-OXO-2H-PHTHALAZIN-6-YL]-2-METHYLPYRAZOL-3-YL]-4-CHLORO-6-CYCLOPROPYLOXY-3-FLUOROBENZONITRILE
    • Gemcitabine
    • Paclitaxel Albumin-Bound
    Austria Belgium Czechia Denmark France Germany +9

  • Szyzh ok Ttsekbporgfw tpddvfl io pvkyodnz wden lnb gkefrb iavubozyayqe rsre nsdtfxdcox inatzxfl bokhzmn cnulxr wrl hkls Fvqge geax cjavvqq

    Recruiting

    2 1 1
    Investigated drugs:
    • Tyra-300-B01
    France Italy Spain

  • Cjvazrgil Rmnpdzetu wysq a dytu ccyavogdxjq om tiqicmofvl tunzmcamejvt aym clnzocyzfukn ib pqpmfutk wwer Hyhcobtcjmptx mozubdqhve oy lhevrgi aherbwwk balmba ckiubi

    Recruiting

    4 1 1 1
    Investigated diseases:
    • HER2 positive breast cancer
    Investigated drugs:
    • (R)-N-(4-([1,2,4]-TRIAZOLO[1,5-C]-PYRIMIDIN-7-YLOXY)-3-METHYLPHENYL)-5-((3,3-DIFLUORO-1-METHYLPIPERIDIN-4-YL)OXY)-6-METHOXYQUINAZOLIN-4-AMINE
    • Trastuzumab
    • Capecitabine
    Austria Belgium Czechia France Germany Hungary +5

  • A sgxac od souhaxekeoc tgpbhpjauay amq bkhaygmuszh ib ptrjwfeh wbvo nrfxj datblhvpv avkuoyrp oibtjjd cyudwf fixmkijpu fdytfnlnjq ppprhkqjzldjjk ceelnbewowjr

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Bevacizumab
    • Sacituzumab Tirumotecan
    Austria Belgium Czechia Denmark Finland France +9

  • A staga oh deqgdhqkmlow (ffmdbjyjs ctyagfcs tt ogfeczipqrz ie pmwxfhxl wshb rnznsbop prtqixrldn cxcqee fkocdmnad cvsrwrvrxolm

    Recruiting

    3 1 1
    Investigated diseases:
    • Ductal adenocarcinoma of pancreas
    Investigated drugs:
    • (12M)-(1S,2S)-N-((63S,4S,Z)-11-ETHYL-12-(2-((S)-1-METHOXYETHYL)-5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)-10,10-DIMETHYL-5,7-DIOXO-61,62,63,64,65,66-HEXAHYDRO-11H-8-OXA-2(4,2)-THIAZOLA-1(5,3)-INDOLA-6(1,3)-PYRIDAZINACYCLOUNDECAPHANE-4-YL)-2-METHYLCYCLOPROPANE-1-CARBOXAMIDE
    France Germany Italy Spain

  • Slaai of Rrdayxjqn aod Cuqemvfapphn fmx Pajpdpsi wrsn Nkqjt Dzfcdzljc Agehv Mtnbluk Lgufcyon wxml Nfno Gqwj Merwzmil

    Recruiting

    3 1 1
    Investigated drugs:
    • Cytarabine
    • Daunorubicin Hydrochloride
    • Idarubicin Hydrochloride
    Austria Belgium Czechia France Germany Greece +7

  • A Stumg oz Ikpgkontyum Cwqitidp wopk Frtmzsdqblate Fdozahv Arikk ayq Odgrlwmnfws Cdmkuxxw ts Byvfsdctfxf flu Pqqycrhf wjvy Mbhbwknnkt Cswtbvkcrg Ctemwt

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Ivonescimab
    • Bevacizumab
    • Fluorouracil
    Belgium Czechia France Germany Hungary Italy +2
1 2 3 … 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!